Magnum acquires Orliman from Riverside

Under Riverside's tenure, Orliman undertook a buy-and-build expansion strategy, bolting on French orthopaedic company Soft Medical Europe in December 2014. The company has also invested in new product development, expanded its international sales and made numerous senior appointments.

The sale represents a return for Riverside Europe Fund IV, a €420m vehicle that closed in November 2010.

Previous funding
Riverside acquired Orliman in 2011 from the company's founding owners, the Mansergas family.

Company
Headquartered in Valencia and founded in 1980, Orliman produces non-invasive orthopaedic devices.

The company stated its sales and EBITDA have increased by around 50% under Orliman's tenure, with 70% of its revenues accounted for by exports. The company generated a turnover of €14m in the year prior to the GP's acquisition.

People
Riverside principal Rafael Álvarez-Novoa led the deal alongside vice-president Damien Gaudin and operating executive Juan Rufilanchas.

Advisers
Vendor – Montalban Atlas Capital (Corporate finance); KPMG (Corporate finance); Garrigues (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Buyouts
• Southern Europe
• Healthcare
• Riverside
• Spain